NCT05743517 Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
| NCT ID | NCT05743517 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Ovary Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 192 participants |
| Start Date | 2023-09-15 |
| Primary Completion | 2028-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 192 participants in total. It began in 2023-09-15 with a primary completion date of 2028-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary purpose of the study is to determine which of four components (symptom-burden tailored app, exercise partner, oncology provider engagement, coaching) added to a core intervention of a wearable activity tracker and commercially available app, will improve physical activity. The findings will generate meaningful knowledge about how to best increase physical activity in older gynecologic cancer patients receiving systemic cancer therapies to improve quality of life and cancer-specific survival.
Eligibility Criteria
Inclusion Criteria: * Female; \> 60 years of age * Diagnosis of endometrial/uterine, ovarian, cervical or vulvar/vaginal cancer * Undergoing or planning to undergo any systemic treatment for a gynecologic malignancy (e.g., chemotherapy, immunotherapy, anti-angiogenic therapies, targeted therapies, etc.) * Willing to try to identify an exercise partner to participate with them, if needed * Fluent in English Exclusion Criteria: * Uncontrolled cardiovascular disease or other major contraindications to physical activity * Active brain metastases * Cognitive or functional limitations that preclude a patient's ability to participate in the physical activity intervention * Pregnant women or prisoners
Contact & Investigator
Emma Barber, MD, MS
PRINCIPAL INVESTIGATOR
Northwestern University
Frequently Asked Questions
Who can join the NCT05743517 clinical trial?
This trial is open to female participants only, aged 60 Years or older, studying Ovary Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05743517 currently recruiting?
Yes, NCT05743517 is actively recruiting participants. Contact the research team at anne@northwestern.edu for enrollment information.
Where is the NCT05743517 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05743517 clinical trial?
NCT05743517 is sponsored by Northwestern University. The principal investigator is Emma Barber, MD, MS at Northwestern University. The trial plans to enroll 192 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.